Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 176

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Hylan versus hyaluronic acid for osteoarthritis of the knee: A systematic review and meta‐analysis

Open access
Reichenbach, Stephan, Blank, Sacha, Rutjes, Anne W. S., Shang, Aijing, King, Elizabeth A., Dieppe, Paul A., Jüni, Peter, Trelle, Sven · 2007 · Arthritis Care & Research

Abstract

Objective: To compare the effectiveness and safety of intraarticular high‐molecular hylan with standard preparations of hyaluronic acids in osteoarthritis of the knee. Methods: We performed a systematic review and meta‐analysis of randomized controlled trials comparing hylan with a hyaluronic acid in patients with knee osteoarthritis. Trials were identified by systematic searches of Central, Medline, EMBase, Cinahl, the Food and Drug Administration, and Science Citation Index supplemented by hand searches of conference proceedings and reference lists (last update November 2006). Literature screening and data extraction were performed in duplicate. Effect sizes were calculated from differences in means of pain‐related outcomes between treatment and control groups at the end of the trial, divided by the pooled standard deviation. Trials were combined using random‐effects meta‐analysis. Results: Thirteen trials with a pooled total of 2,085 patients contributed to the meta‐analysis. The pooled effect size was −0.27 (95% confidence interval [95% CI] −0.55, 0.01), favoring hylan, but between‐trial heterogeneity was high (I 2 = 88%). Trials with blinded patients, adequate concealment of allocation, and an intent‐to‐treat analysis had pooled effect sizes near null. The meta‐analyses on safety revealed an increased risk associated with hylan for any local adverse events (relative risk [RR] 1.91; 95% CI 1.04, 3.49; I 2 = 28%) and for flares (RR 2.04; 95% CI 1.18, 3.53; I 2 = 0%). Conclusion: Given the likely lack of a superior effectiveness of hylan over hyaluronic acids and the increased risk of local adverse events associated with hylan, we discourage the use of intraarticular hylan in patients with knee osteoarthritis in clinical research or practice.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.23103

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 176

Metadata

Authors
Reichenbach, S., Blank, S., Rutjes, A. W. S., Shang, A., King, E. A., Dieppe, P. A., Jüni, P., & Trelle, S.
Venue
Arthritis Care & Research
Publisher
Wiley
Published
2007-11-29
Volume
57
Issue
8
Pages
1410-1418
ISSN
  • 0893-7524 (ISSN-L)
  • 1529-0123
OpenAlex
W2088810278
Cited by
176
References
6
FWCI
1.56
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hylan versus hyaluronic acid for osteoarthritis of the knee: A systematic review and meta‐analysis. https://app.cochat.ai/papers/10.1002/art.23103
The paper
Reichenbach, S., Blank, S., Rutjes, A. W. S., Shang, A., King, E. A., Dieppe, P. A., Jüni, P., & Trelle, S. (2007). Hylan versus hyaluronic acid for osteoarthritis of the knee: A systematic review and meta‐analysis. Arthritis Care & Research. https://doi.org/10.1002/art.23103

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.